1,4-Dioxa-8-azaspiro[4.5]decane hydrochloride, 95.0%, 5g

Assortment box, PP, 18 compartments, transparent, L 250 x W 170 x H 46 mm 1 piece

2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole, 95.0%, 100g

(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline, 98%, 250mg

(2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95.0%, 25g

Methyl 2-amino-5-iodothiazole-4-carboxylate, 97%, 250mg

iScope IS.1158-PLPHi Biocular for phase contrast with Plan phase IOS objectives and Rackless cross stage (infinity - ergonomic tilting head)

(S)-2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acid, 95.0%, 1g

(S)-2-(3-PYRROLIDINYL)-2-PROPANOL HCL, 95.0%, 1g

5-Methyl-1-phenylpyrazole-3-carboxylic acid, 95.0%, 5g

(2,3-Dihydrobenzofuran-6-yl)methanol, 95.0%, 500mg

3-Bromo-5-fluoro-2-methylbenzoic acid, 97%, 100mg

3-Hydroxybenzylhydrazine dihydrochloride, 98.0%, 1g